Yahoo Finance

T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally

LEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ...
MarketWatch

T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test

Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...
Nasdaq

T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...
Yahoo Finance

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

"We are pursuing FDA Breakthrough Device Designation for our novel direct-from-blood C. auris diagnostic test to potentially accelerate the path toward FDA clearance and commercialization,” stated ...